Pharmacy compounding for oncology drugs-dallas VA
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36C25726D0024
- Awardee
-
Optum Infusion Services 308, LLC UEI RN5UVE9XMJN4 Part of Unitedhealth Group Incorporated
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 1 $1,200,000 obligated
Award facts
- Opportunity
-
- Q517--Dallas Pharmacy Compounding-Oncology Solicitation · 36C25726Q0033 · Posted Oct 7, 2025
- Combined order value
- $1,200,000 Current and potential, with all options
- Last date to order 20% complete
- IDV ceiling 20% used
- $6,000,000.00
- Maximum order
- $1,200,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 17 awarded a single-award indefinite-delivery contract to Optum Infusion Services 308, LLC for pharmacy compounding services focused on oncology drugs at the Dallas VA Healthcare System, with a contract ceiling of $6 million and an award date of November 1, 2025.
The contract runs from November 1, 2025, through October 31, 2030. Performance occurs at the Dallas VA Medical Center (4500 S Lancaster Road, Dallas, Texas 75216) and the Garland VA Clinic, with services including chemotherapy preparation for oncology patients, daily shift reporting, and monthly activity reporting. The contractor must operate in CETA CAG certified primary and secondary engineering control environments, deliver next-day prepared chemotherapy compounds, and maintain compliance with Joint Commission standards, VA healthcare policies, and USP 797, 795, and 800 requirements.
The underlying solicitation (RFQ 36C25726Q0033), posted October 7, 2025, with responses due October 15, 2025, sought chemotherapy compounding services evaluated on technical capability, price, and past performance. The contract structure is five-year IDIQ with a base period from November 1, 2025, through October 31, 2026, followed by four additional option years, and carries a minimum guaranteed value of twelve thousand dollars.
A $1.2 million delivery order was issued under this IDIQ on November 1, 2025, to Optum Infusion Services 308, LLC for Dallas VA pharmacy compounding for oncology drugs, running through October 31, 2030, on a firm fixed-price basis.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Dallas VA pharmacy compounding for oncology drugs | Veterans Integrated Service Network 17 (VHA) | $1,200,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C25726D0024?
36C25726D0024 was awarded to Optum Infusion Services 308, LLC by Veterans Integrated Service Network 17 (Veterans Health Administration) on November 1, 2025.
How much is contract 36C25726D0024 worth?
Orders under 36C25726D0024 have obligated $1,200,000. 36C25726D0024's own ceiling is $6,000,000. A single order can be worth up to $1,200,000.
How many orders have been placed under contract 36C25726D0024?
1 order has been placed under 36C25726D0024, the latest on November 1, 2025.
Who can order from contract 36C25726D0024?
36C25726D0024 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36C25726D0024 competed?
The extent of competition for 36C25726D0024 was competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV